Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
04/2003
04/22/2003CA2239187C Inhibitors of farnesyl protein transferase
04/22/2003CA2117471C Benzisoxazole derivatives and pharmaceutical compositions containing them
04/17/2003WO2003031443A1 Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
04/17/2003WO2003031442A1 Heterocyclic compounds, oxazole derivatives, process for preparation of the same and use thereof
04/17/2003WO2003031441A1 Multiple action compounds
04/17/2003WO2003031438A1 3-[4-(substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2-indolinone derivatives as kinase inhibitors
04/17/2003WO2003031436A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
04/17/2003WO2003031432A1 Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor
04/17/2003WO2003031431A1 Cyclic sulfone derivatives as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace)
04/17/2003WO2003031428A1 Stereospecific process for the synthesis of 2-yl chroman derivatives
04/17/2003WO2003031414A1 Novel heterocyclic compound and anti-inflammatory agent
04/17/2003WO2003031407A2 β-LACTAMYL VASOPRESSIN VlaANTAGONISTS
04/17/2003WO2003030898A1 Modulators of ccr5 chemokine receptor activity
04/17/2003WO2003030897A1 Pyrrolidinone derivatives
04/17/2003WO2003030889A1 Para-amino benzoic acids as integrin antagonists
04/17/2003WO2003013484A3 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents
04/17/2003WO2003005999A3 Methods of treating cytokine mediated diseases
04/17/2003WO2002098852A3 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
04/17/2003WO2001094341A9 Quinazoline derivatives for the treatment of tumours
04/17/2003WO2001017965A3 Cyanopiperidines as pesticides
04/17/2003WO1999064401A3 Imidazolyl derivatives and their use as somatostatin receptor ligands
04/17/2003US20030073850 Incontinence; nasal congestion
04/17/2003US20030073836 Heteroarylcarboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions
04/17/2003US20030073834 Purine compounds having PDE IV inhibitory activity and methods of synthesis
04/17/2003US20030073718 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease
04/17/2003US20030073706 Fused thiophone derivatives and drugs containing the same as the active ingredient
04/17/2003US20030073702 Cyclic oxyguanidine pyrazinones as protease inhibitors
04/17/2003US20030073696 Oxazolidinone photoaffinity probes
04/17/2003US20030073688 Novel substituted benzoxazines as integrin antagonists
04/17/2003US20030073682 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
04/17/2003US20030073680 Therapy for Tay-sach, Gaucher diseases
04/17/2003US20030073669 N-heterocyclic derivatives as NOS inhibitors
04/17/2003US20030073205 Production of polyketides
04/17/2003CA2463198A1 Pyrrolidinone derivatives
04/17/2003CA2462950A1 3-[4-(substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2-indolinone derivatives as kinase inhibitors
04/17/2003CA2462860A1 Stereospecific process for the synthesis of 2-yl chroman derivatives
04/17/2003CA2462301A1 Para-amino benzoic acids as integrin antagonists
04/17/2003CA2458456A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
04/16/2003EP1302468A1 Processes and intermediates for manufacturing retroviral protease inhibiting compounds
04/16/2003EP1302466A1 Benzoxazole compound, process for producing the same, and herbicide
04/16/2003EP1301509A1 Multifunctional coupling agents with cyclic iminoester and iminoether groups, method for producing the same and use thereof
04/16/2003EP1301506A1 Cyclic amino acid derivatives
04/16/2003EP1301487A2 Viral polymerase inhibitors
04/16/2003EP1301483A1 1-aryl-4-alkyl halide-2(1h)-pyridones and their use as herbicides
04/16/2003EP1301482A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists
04/16/2003EP1301469A1 Preparation of 4-thioalkylbromobenzene derivatives
04/16/2003EP1301458A1 Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis
04/16/2003EP1200428B1 Substituted benzoxazoles
04/16/2003EP1015436B1 Morpholinones as light stabilizers
04/16/2003EP0944608B1 4-cyclohexylphenyl-oxazolines and their use for controlling animal pests
04/16/2003EP0880508B1 Quinazoline derivatives as vegf inhibitors
04/16/2003CN1411460A Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
04/16/2003CN1411457A Substituted pyrroles
04/16/2003CN1411456A Chemokine receptor binding heterocyclic compounds
04/16/2003CN1411445A Method for preparing 3-hydroxypicolinic acid derivatives
04/16/2003CN1410422A Benzfuran compound
04/16/2003CN1105717C Substituted sulphonylamino (thio) carbony/compounds
04/16/2003CN1105716C Benzimidazole derivatives with antihistaminic activity
04/16/2003CN1105706C Cyclic amidino agents useful as nitric oxide synthase inhibitors
04/15/2003US6548671 Quinoxalinyl amide derivatives
04/15/2003US6548667 For prevention and treatment of diseases caused by overexpression and overactivation of matrix metalloproteinase
04/15/2003US6548666 Tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them
04/15/2003US6548638 Peptoid and nonpeptoid containing α-keto oxadiazoles as serine protease inhibitors
04/15/2003US6548548 Cardiovascular disorders; anticholesterol agents
04/15/2003US6548533 Pyrrolidine carboxylic Acid or ester derivatives are useful for treating alpha 4 beta 1 mediated cell adhesion
04/15/2003US6548529 Heterocyclic containing biphenyl aP2 inhibitors and method
04/15/2003US6548516 (NMDA=N-methyl-D-aspartate); where the heteroaryl is 3H-benzoxazol-2-one, 3H-benzothiazol-2-one, 3H-benzimidazol-2-one or indolin-2-one; excitatory amino acid antagonists for combating neurodegenerative disorders
04/15/2003US6548499 Substituted quinoxaline derivatives as interleukin-8 receptor antagonists
04/15/2003US6548495 Dihydro-benzo [B] [1,4] diazepin-2-one derivatives
04/15/2003US6548451 Use of derivatives of 2-oxopyrrole as crop protection agents and novel 2-oxopyrroles
04/15/2003CA2169737C Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives
04/10/2003WO2003029238A1 Chroman derivatives as 5-hydroxytryptamine-6 ligands
04/10/2003WO2003029224A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003WO2003029216A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003WO2003029210A2 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
04/10/2003WO2003028729A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003WO2003028721A2 Substituted benzimidazole compounds and their use for the treatment of cancer
04/10/2003WO2003028720A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
04/10/2003WO2003028650A2 Benzimidazolidinone derivatives as muscarinic agents
04/10/2003WO2003028641A2 Mch receptor antagonists
04/10/2003WO2003028458A1 N-thio-nicotinamide derivatives and related compounds for use as pesticides
04/10/2003WO2002102793A3 Quinazolinediones as antibacterial agents
04/10/2003WO2002096890A3 Regioselective mitsunobu reaction, particularly for preparing bactericidal oxazolidinones
04/10/2003WO2002094203A3 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
04/10/2003WO2002078639A3 A method of treating proliferative diseases using eg5 inhibitors
04/10/2003WO2002070540A3 Peptide deformylase inhibitors
04/10/2003WO2002041889A3 Indolsulfonyl compounds useful in the treatment of cns disorders
04/10/2003WO2001083800A3 Heterologous production of polyketides
04/10/2003US20030069430 Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects
04/10/2003US20030069299 Substituted indolinones, preparation thereof and their use as pharmaceutical compositions
04/10/2003US20030069297 4-aryl substituted indolinones
04/10/2003US20030069291 3-heterocyclylpropanohydroxamic acid PCP inhibitors
04/10/2003US20030069277 Anticancer agents
04/10/2003US20030069275 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
04/10/2003US20030069272 Prevent joint stiffness; adjust concentration of synovial fluid
04/10/2003US20030069267 Modulators of protein tyrosine phosphatases (PTPases)
04/10/2003US20030069261 Therapy for eating disorders, sexual disorders, psychological disorders
04/10/2003US20030069258 Novel guanidine mimics factor Xa inhibitors
04/10/2003US20030069257 Benzimidazole and pyridylimidazole derivatives
04/10/2003US20030069252 Viricides; antiinflammatory agents